Stockscreener 앱 받기
3.55
940.45%
3.2088
전일 마감가:
$0.3412
열려 있는:
$3.31
하루 거래량:
236.15K
Relative Volume:
4.14
시가총액:
$67.12M
수익:
$389.00K
순이익/손실:
$-13.13M
주가수익비율:
-3.4389
EPS:
-1.0323
순현금흐름:
$-11.90M
1주 성능:
+891.62%
1개월 성능:
+1,138%
6개월 성능:
+463.49%
1년 성능:
+36.15%
1일 변동 폭
$2.99
$3.91
1주일 범위
$0.2912
$3.91
52주 변동 폭
$0.2637
$3.91
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Compare CLGN vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
3.55 | 6.01M | 389.00K | -13.13M | -11.90M | -1.0323 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-02-17 | 개시 | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd 주식(CLGN)의 최신 뉴스
Inside Loewenbaum's capped warrant-backed bet on CollPlant (CLGN) - Stock Titan
Bioink Market Set to Booming Growth 2026-2033 | CELLINK, - openPR.com
What Could CollPlant (NASDAQ:CLGN) Results Signal for Investors? - Kalkine Media
CollPlant (CLGN) Financial Update: The Available Earnings Metric Delivers a Miss for the Current Session; Shares Move Lower 1.66% in the Available RecordProfit Announcement - vinanet.vn
CollPlant Shareholders Approve All Proposals at August 18 Extraordinary Meeting - TipRanks
CollPlant (CLGN) shareholders back both August EGM items - Stock Titan
CLGN Q4 2025 Earnings: Wider-than-Expected Loss Highlights Pre-Revenue R&D PushPre-Earnings Drift - vinanet.vn
CollPlant Biotechnologies Bolsters Authorized Share Capital and Validates Resale Shares After July Private Placement - TipRanks
CollPlant Biotechnologies (CLGN) lifts share capital, files new resale opinion - Stock Titan
CLGN Q4 2025 Earnings: Wider-Than-Expected Loss Pressures Shares as R&D Investment ContinuesTrough Earnings Signal - vinanet.vn
CLGN Q4 2025 Earnings: Wider-than-Expected Loss Sends Shares Down 9%CFO Commentary Report - vinanet.vn
Loewenbaum group holds 33% CollPlant (CLGN) stake after warrant deal - Stock Titan
CollPlant Shareholders Approve Proposal at Extraordinary General Meeting - theglobeandmail.com
CollPlant Biotechnologies (CLGN) investors approve EGM proposal - Stock Titan
CollPlant Biotechnologies (NASDAQ: CLGN) reverse split to boost share price - Stock Titan
CollPlant Biotechnologies (CLGN) holders buy 1,764,706 shares plus new warrants - Stock Titan
Collplant Biotechnologies Ltd (CLGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Collplant Biotechnologies Ltd - TradingKey
CLGN|Collplant Biotechnologies Ltd|Price:0.305|Chg%:-0.010 - TradingKey
Collplant Biotechnologies Ltd (CLGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Collplant Biotechnologies Ltd (CLGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CLGN|Collplant Biotechnologies Ltd|Price:0.327|Chg%:+0.012 - TradingKey
CLGN|Collplant Biotechnologies Ltd|Price:0.312|Chg%:+0.040 - TradingKey
Collplant Biotechnologies Ltd (CLGN) Cash Flow - TradingKey
TradingKey - TradingKey
Collplant Biotechnologies Ltd (CLGN) Balance Sheet - TradingKey
CLGN|Collplant Biotechnologies Ltd|Price:0.339|Chg%:+0.019 - TradingKey
CollPlant Biotechnologies Ltd. Revenue Breakdown – NASDAQ:CLGN - TradingView
Collplant Biotechnologies Ltd (CLGN) Institutional Confidence - TradingKey
CollPlant Biotechnologies Market Sentiment - Benzinga
CollPlant Biotechnologies (CLGN) completes $10.4M exempt private securities deal - Stock Titan
CollPlant Biotechnologies (CLGN) files to resell 31M shares from 2026 PIPE - Stock Titan
CollPlant Biotechnologies Ltd SEC Filing (Jul 17, 2026) - Stock Titan
CollPlant Biotechnologies (CLGN) Slides 3.8% – Key Support Level in FocusDividend ETF - vinanet.vn
Collplant Biotechnologies Ltd (CLGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CollPlant Biotechnologies files prospectus for 31.047M share offering - scanx.trade
CollPlant Biotechnologies Files Prospectus for Resale of 31 Million Shares - Moomoo
CLGN: Selling Stockholders Plan to Offer 31.05 Million Shares - GuruFocus
CollPlant (CLGN) files F-3 to register 31.05M shares from June 2026 PIPE - Stock Titan
CollPlant Biotechnologies Calls July 29 Extraordinary Meeting to Approve Major Share Capital Increase - The Globe and Mail
CollPlant (NASDAQ: CLGN) targets 500M authorized shares in shareholder vote - Stock Titan
CollPlant Biotechnologies (CLGN) Q4 2025 Earnings: Wider‑Than‑Expected Loss Highlights Pre‑Revenue Challenges - dars.gov.et
CollPlant (Nasdaq: CLGN) raises $2.6M in share and warrant private deal - Stock Titan
CollPlant raises $2.6M to fund regenerative medicine push - Dealroom
CollPlant (CLGN) Secures $2.6 Million in Private Placement Offer - GuruFocus
CollPlant announces $2.6 million private placement By Investing.com - Investing.com Australia
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT - PR Newswire
CollPlant Biotechnologies Ltd. announced that it expects to receive $2.6 million in funding - marketscreener.com
CollPlant Biotechnologies (CLGN) Q4 2025 earnings summary - Quartr
Enterprise value to revenue forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView
Price to earnings forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView
Collplant Biotechnologies Ltd (CLGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
0.31%
자본화:
|
볼륨(24시간):